Epigral Ltd
company logo

Epigral Ltd

EPIGRAL Share Price

BSE:543332

NSE:EPIGRAL

1011.8

21.80 (2.20%)

As on April 8, 2026 at 03:48 PM
Loading chart...

Performance

Loading performance...

990

950.90

128550

13.01

10

Fundamentals

4,101.88Cr

12.14

1.95

0.47

78.33

0.63%

487.03

About

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products. The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021. The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21. The Company is now among the leading players in India's chlor alkali industry. In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited. The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive Power Plant). The timely commissioning of the plants represented the faith of the management in the long-term potential of the sector and country. The Caustic Soda capacity was expanded by 1,27,000 TPA to 2,94,000 TPA and commissioned in June 2020. The Captive Power Plant capacity was increased by 36 MW to 96 MW, commissioned in June 2020. The Company commissioned a 60,000 TPA Hydrogen Peroxide plant in July 2020. The Company further commissioned the capacity expansion of Caustic Soda manufacturing facility to 400 KTPA by adding 106 KTPA facility, along with expansion of 36 MW Captive Power Plant on 30th September, 2022. It commissioned Epichlorohydrin (ECH) manufacturing facility with a capacity of 50,000 TPA on 1st June, 2022, which is used in varied applications, such as Epoxy Resin, Water Treatment Chemicals, Textiles, Pharmaceuticals, Paper Reinforcement, Synthetic Glycerine, etc. It commissioned CPVC Resin manufacturing facility with a capacity of 30,000 TPA capacity on 18th July, 2022. In 2024-25, Company commissioned additional capacity of 45,000 TPA of CPVC Resin facility in April, 2024, reaching total capacity of CPVC Resin to 75,000 TPA. It also forward integrated and commissioned CPVC Compound facility of 35,000 TPA in June, 2024. Company has announced expansion of additional 75,000 TPA capacity of CPVC Resin plant at its Dahej facility in Gujarat. With this expansion, Company's total CPVC resin capacity reaches a remarkable 1,50,000 TPA in FY25. Company has commissioned India's First Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on 24th March, 2025.

Maulik Jayantibhai Patel

2007

EPIGRAL

NameDesignation
Maulik Jayantibhai PatelChairman & Managing Director
Kaushal Ashishbhai SoparkarExecutive Director
Karana Rameshbhai PatelNon Executive Director
Ankit Natwarlal PatelNon Executive Director
Darshan Anandbhai PatelNon Executive Director
Manubhai Khodidas PatelIndependent Director
Sanjay K AsherIndependent Director
Kanubhai S PatelIndependent Director
Raju SwamyIndependent Director
Gaurang Trivedi.Company Sec. & Compli. Officer
Priyanka Agarwal ChopraIndependent Director

Epigral Ltd FAQs

How do I Buy Epigral Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Epigral Ltd shares in BlinkX.

What is the Share Price of Epigral Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Epigral Ltd's share price is ₹1011.8 as of 2026-04-08.

What is the PE ratio of Epigral Ltd?

close

Epigral Ltd's P/E ratio is 12.14 times as of 2026-04-08.

What is the PB ratio of Epigral Ltd?

close

Epigral Ltd's most recent financial reports indicate a price-to-book ratio of 1.95, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Epigral Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Epigral Ltd's market capitalization is ₹4101.88 Cr as on 2026-04-08.

What is the ROE of Epigral Ltd?

close

The current financial records of Epigral Ltd show a 22.59% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Epigral Ltd?

close

According to Epigral Ltd's most recent financial filings, the company has a total asset value of ₹698.64, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Epigral Ltd?

close

The 52-week high/low price of a Epigral Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Epigral Ltd's 52-week high and low as of 2026-04-08 are ₹2114 and ₹807, respectively.